The American Academy of Dermatology (AAD) has designated May as National Melanoma/Skin Cancer Detection and Prevention Month. In 1996, an estimated 1 million cases of skin cancer will be diagnosed, of which approximately 95% will be squamous cell or basal cell carcinomas (1 ). Although the incidence of melanoma is lower than those of squamous cell and basal cell carcinomas, the case-fatality rate is highest for persons with melanoma. During 1973During -1992, mortality from melanoma increased 34%-the third highest increase of all cancers (2 ).
*Defined as knowledge that melanoma is a type of cancer or specifically a type of skin cancer. † n=1001 adults aged ≥18 years in 47 states (Alaska, Arizona, Hawaii, and Missouri were excluded). Percentages may not total 100% because some respondents gave answers that are not included in this analysis. § Odds of knowing that melanoma is a type of skin cancer versus any other response in the specific category as compared with the reference category. ¶ Confidence interval. ** Numbers for other racial groups were too small for meaningful analysis. 
Risk Factors and Prevention Measures for Melanoma and Other Skin Cancers

Measures to Prevent Skin Cancer
• Reduce direct exposure to the sun, especially from 10 a.m. to 4 p.m.
• Wear a broad-brimmed hat and clothes that protect sun-exposed areas of the body • Use sunscreen with a sun protection factor (SPF) ≥15 as protection against ultraviolet A and ultraviolet B radiation • Refer to the daily ultraviolet index (available in 58 cities) when planning outdoor activities.
A national health objective for the year 2000 is to increase to at least 60% the proportion of persons of all ages who limit sun exposure, use sunscreens and protective clothing when exposed to sunlight, and avoid artificial sources of UV light (e.g., tanning beds) (7 ) . Based on the 1992 National Health Interview Survey, substantial progress must be made to meet these objectives. Survey results indicate that only 31% of U.S. adults limited their exposure to the sun, 28% routinely used sunscreen, and 28% wore protective clothing (7 ) .
The findings from this survey are assisting CDC and the AAD in the National Skin Cancer Prevention Education Program, a collaborative effort to increase public awareness about skin cancer and to help achieve the year 2000 objectives for skin cancer prevention. Goals of this program are to develop and disseminate educational messages for children, their parents, and other caregivers; develop guidelines for school curricula; evaluate the utility and value of the UV index; and develop educational messages for health-care providers. Recommendations to prevent the development of melanoma and other skin cancers should emphasize behaviors necessary to reduce or minimize exposure to the sun and UV radiation (see box).
Asthma Mortality and Hospitalization Among Children and Young Adults -United States, 1980-1993
Asthma -Continued Asthma is the most common chronic illness in childhood and is characterized by variable airflow obstruction with airway hyperresponsiveness. In the United States, asthma affects an estimated 14-15 million persons, including 4.8 million (6.9%) aged <18 years (1 ) . In 1993, asthma accounted for an estimated 198,000 hospitalizations and 342 deaths among persons aged <25 years. To characterize national trends in mortality and hospitalizations attributable to asthma among children and young adults (persons aged <25 years) during 1980-1993, CDC analyzed mortality data from its multiple cause-of-death files and hospitalization data from the National Hospital Discharge Survey. This report summarizes the results of that analysis, which indicate that asthma-related mortality and hospitalization rates are increasing among persons aged <25 years.
Deaths attributed to asthma were based on the International Classification of Diseases, Ninth Revision (ICD-9), codes 493.0-493.9. Asthma-related hospitalizations were classified as those in which asthma was the first-listed discharge diagnosis. Data were analyzed by race because of previously reported differences in race-specific rates of death and hospitalization attributed to asthma (2 ) . Race-specific analyses were restricted to blacks and whites because numbers for other races were too small to calculate stable estimates.
During 1980-1993, asthma accounted for 3850 deaths among persons aged 0-24 years. The annual age-specific asthma death rate increased 118% (from 1.7 to 3.7 per million population). During this period, death rates for asthma consistently were
Breathe Easy Month ® , May 1996
The American Lung Association (ALA) has designated May as Breathe Easy Month ® as part of its ongoing effort to educate the public about issues relating to respiratory health. Lung disease is the third leading cause of death in the United States. Each year, approximately 335,000 persons in the United States die from lung disease, including asthma, emphysema, chronic bronchitis, and lung cancer.
Clean Air Week ® , May 20-27, emphasizes air pollution and its relation to lung disease. Air pollution, both indoors (e.g., environmental tobacco smoke) and outdoors (e.g., ozone), is an important contributor to respiratory illnesses such as asthma. ALA recommends reducing exposure to air pollutants and home testing for specific pollutants such as radon and carbon monoxide. In addition, air quality can be improved by supporting state and local clean air regulations and making homes and workplaces smoke-free.
During May, local ALA offices will offer programs on management of asthma and smoking cessation and will host Clean Air Challenge ® cycling, running, and walking fundraising events. Additional information about Breathe Easy Month ® , Clean Air Week ® , and related activities is available from local ALA offices (telephone [800] 586-4872 or [212] 315-8700).
highest among blacks aged 15-24 years ( Figure 1 ). Although the death rate among children aged 0-4 years increased slightly during 1980-1993 (from 1.8 to 1.9 per million population), the rate in 1993 had decreased from that in 1992 (2.4 per million population). In 1993, among children aged 0-4 years, blacks were six times more likely to die from asthma than whites, and boys were 1.4 times more likely than girls.
Among children aged 5-14 years, the asthma death rate nearly doubled from 1980 to 1993 (from 1.7 to 3.2 per million population). In 1993, among children aged 5-14 years, blacks were four times more likely than whites to die from asthma, and boys were 1.3 times more likely than girls.
Among persons aged 15-24 years, the asthma death rate doubled from 1980 to 1993 (from 2.5 to 5.2 per million population). In 1993, among persons aged 15-24 years, blacks were six times more likely than whites to die from asthma, and males were 1.5 times more likely than females.
From 1980 to 1993, the annual hospitalization rate for asthma among persons aged 0-24 years increased 28% (from 16.8 to 21.4 per 10,000 population). Hospitalization rates consistently were highest among blacks. In 1993, among persons aged 0-24 years, blacks were 3.4 times more likely than whites to be hospitalized for asthma. Although the rate of hospitalization for asthma was highest and increased the most among children aged <1 year (from 35.6 to 64.7 per 10,000 population) (Figure 2 ), the rate in 1993 had decreased from that in 1992 (66.3 per 10,000 population). Among children aged 1-4 years, the rate of hospitalization increased during 1980-1992 (from 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 † Race-specific analyses were restricted to blacks and whites because numbers for other races were too small to calculate stable estimates.
38.3 to 60.1 per 10,000 population), but decreased in 1993 (43.6 per 10,000 population) because of a decrease in the number of participating hospitals. In 1993, boys aged <5 years were 1.7 times more likely than girls to be hospitalized for asthma. Among persons aged 5-24 years, the rates of asthma hospitalization remained relatively constant during 1980-1993. In 1993, among persons aged 5-14 years, boys were 1.3 times more likely than girls to be hospitalized for asthma, and among those aged 15-24 years, females were 2.1 times more likely than males to be hospitalized. Editorial Note: Asthma is a multifactorial disease that has been associated with familial, infectious, allergenic, socioeconomic, psychosocial, and environmental factors. Decreases in pulmonary functions and exacerbations of asthma have been associated with ambient air pollutants (e.g., ozone, sulfur dioxide, nitrogen dioxide, acid aerosols, and particulate matter) (3 ), indoor pollutants (e.g., tobacco smoke), and allergens (e.g., dust mites) (4 ) . Approximately 25% of children in the United States reside in areas that exceed the federal standard for ozone (5 ) .
Although asthma-associated mortality has increased among persons aged <25 years, hospitalizations for asthma have increased primarily among children aged <5 years. The increase among young children may be related to changes in diagnostic practices, changes in coding and reimbursement, or increases in morbidity (6 ). One of the national health objectives for the year 2000 is to decrease asthma morbidity, as measured by a reduction in hospitalizations for asthma, among children aged ≤14 years to no more than 18.3 per 10,000 population (baseline: 22.9 per 10,000 persons) (objective 11.1) (7 ). In 1993, the hospitalization rate for children aged ≤14 years was 28.0 per 10,000 population. Hospitalizations for and mortality related to asthma can be prevented, in part, by improving surveillance, diagnostic measures, and patient management; providing patient education; targeting high-risk populations (8 ) ; and evaluating interventions in the home environment (e.g., reducing levels of house dust mites and exposure to environmental tobacco smoke) (6, 8, 9 ) .
Additional information about these prevention measures or other asthmaprevention materials are available from the National Heart, Lung and Blood Institute Information Center, telephone (301) 251-1222, or the local offices of the American Lung Association, telephone (800) 586-4872 or (212) 315-8700.
Asthma -Continued
Human Rabies -California, 1995
Human Rabies -Continued In September and November 1995, two men in California died from infection with bat-associated variants of rabies virus. This report summarizes the investigations of these cases.
Case 1
On September 9, 1995, a 27-year-old farm worker in San Benito County was examined in the emergency department (ED) of a local hospital because of a 1-day history of vomiting and severe headache. Computerized axial tomography of the brain and cerebrospinal fluid (CSF) analysis were within normal limits, and he was discharged with a diagnosis of cephalgia. He returned to the ED two additional times that day with complaints of headache and sore throat, for which amoxicillin was prescribed. On September 10, he was admitted to the hospital because of severe supraorbital headache and intermittent vomiting.
Findings on admission included an oral temperature of 103.1 F (39.5 C) and mild nonexudative pharyngitis; in addition, the patient rejected oral medications because of an intermittent inability to swallow. A peripheral white blood cell (WBC) count was 14,000/mm 3 (normal: 5000-10,000/mm 3 ) with 82% neutrophils, 9% lymphocytes, 5% monocytes, and 4% bands. The CSF contained 0 WBC/mm 3 (normal: 0-5 WBC/mm 3 ), total protein of 68 mg/dL (normal: <40 mg/dL), and glucose of 65 mg/dL (normal: 70-110 mg/dL). A chest roentgenogram revealed right lower lobe pulmonary infiltration, and treatment for pneumonia was initiated with intravenous cefuroxime and erythromycin. On September 11, his oral temperature was 104.9 F (40.5 C), and he coughed blood-tinged mucus. He became acutely agitated and confused and required physical restraints. Because of alteration of mental status, later that day he was transferred to a tertiary-care facility.
Findings on admission included an oral temperature of 104.5 F (40.3 C), peripheral WBC count of 17,000/mm 3 , and CSF containing total protein of 124 mg/dL, glucose of 92 mg/dL, and 6 WBC/mm 3 . Nonspecific encephalitis was tentatively diagnosed, and treatment was initiated with acyclovir, ceftizoxime, vancomycin, and doxycycline. Magnetic resonance imaging and electroencephalogram results were consistent with encephalitis. However, analysis of CSF specimens were negative for herpes simplex virus (by polymerase chain reaction [PCR] assay) and bacteria (by standard culture methods). Rabies was included in the differential diagnosis on September 12; the patient became comatose on September 15 and died September 21. A limited autopsy was performed.
A CSF specimen collected September 12 and serum and nuchal skin biopsy specimens collected September 13 were sent to the Viral and Rickettsial Disease Laboratory (VRDL) of the California Department of Health Services and to CDC for rabies testing, and corneal impression specimens were sent to the VRDL. Both laboratories reported the CSF and serum specimens to be negative for rabies antibody (by rapid fluorescent focus inhibition test [RFFIT] assay at CDC and indirect immunofluorescence [IIF] assay at the VRDL). The nuchal skin biopsy was negative for rabies virus antigen by direct fluorescent antibody (DFA) testing at both laboratories (although only two hair follicles were present in the biopsy). The corneal impression specimen was inconclusive for rabies antigen (by DFA) at the VRDL. However, rabies was diagnosed by the VRDL on September 20 based on rising rabies antibody titers of <1:8 to 1:256 by IIF in serum samples collected on September 13 and September 19, respectively. An IIF titer of >1:2048 was detected in a follow-up serum specimen collected September 21, and brain tissue specimens collected at autopsy were positive for rabies virus (by both DFA and PCR assays) at the VRDL on September 25. At CDC, nucleotide sequence analysis of rabies viral nucleic acid from brain tissue implicated a variant of rabies virus associated with Mexican free-tailed bats (Tadarida brasiliensis).
The patient had immigrated from Mexico and had last been in Mexico during November 1994-April 1995. In California, he resided on a ranch that produced vegetables, and he worked primarily in a packing shed; a bat colony inhabited the roof area of the shed. A family member believed that a bat had landed on and was brushed off the patient's chest, but was unable to provide any specific details of the incident. The complete colony of 76 bats, including a mixture of Mexican free-tailed and pallid bat species, was collected for evaluation; all tested negative for rabies.
Rabies postexposure prophylaxis (PEP) was administered to 12 persons (11 coworkers and one health-care professional) because of possible percutaneous or mucous membrane exposure to the patient's vomitus or saliva.
Case 2
On October 26, a 74-year-old resident of Butte County was evaluated in a local ED because of paresthesia and weakness in the right arm and chronic cough. He was discharged but returned to the hospital on October 30 and was admitted because of shortness of breath, confusion, vomiting, and right arm weakness. On admission, he was afebrile; other findings included right arm weakness, bilateral ptosis, severe dysarthria, ataxia, moderate confusion, and a productive cough. He declined to drink fluids and gagged and vomited when offered food. Laboratory findings on admission included a WBC count of 13,000/mm 3 with 88% neutrophils, 4% lymphocytes, 4% monocytes, and 4% bands; CSF containing 3000 red blood cells/mm 3 , 1000 WBC/mm 3 , and total protein of 174 mg/dL; chest radiograph with bilateral pulmonary infiltrates; and nerve conduction abnormalities of the right upper extremity consistent with axonal and demyelinating neuropathy. Admitting diagnoses included pneumonia and cerebrovascular accident.
During the first 24 hours after admission, the patient became progressively agitated, confused, and ultimately unresponsive; he was intubated and placed on mechanical ventilatory support. During November 1-9, he did not regain consciousness and was intermittently febrile (high of 102.7 F [39.3 C]). On November 9, when the patient died, the differential diagnoses included respiratory failure and Guillain-Barré syndrome.
Although rabies was not considered before death, examination of brain material at autopsy revealed intracytoplasmic inclusions consistent with rabies virus infection. On December 30, paraffin-embedded brain specimens were sent to CDC, where rabies antigen was detected by DFA staining. Nucleotide sequence analysis of the specific viral RNA found in the brain tissue identified the rabies virus variant associated with the silver-haired bat (Lasionycteris noctivagans). The diagnosis was confirmed at the California VRDL on January 4 by the detection of rabies virus-specific antibody (by IIF assay; titer of 1:8) in an antemortem sample of CSF.
The patient had lived alone on a ranch in Butte County and herded his cattle to a grazing area in adjacent Lassen County during the summer. Multiple potential sources of exposure to both domestic and wild animals were present in both the grazing area and the ranch. The patient's son reported that the patient would sometimes catch bats, but he knew of no incidents of animal bite.
A total of 76 persons received rabies PEP because of possible contact with the patient's oral and respiratory secretions during his illness. The group of exposed persons included 71 health-care workers, three family members, one housekeeper, and the pathologist who performed the autopsy.
Editorial Note: During 1995, a total of four cases of human rabies were documented in the United States, including the two cases described in this report. In all four cases, the rabies virus variant was associated with insectivorous bats; however, a definite history of bite exposure could not be identified for any of these cases. Characteristics of these cases are consistent with an emerging pattern in the epidemiology of human rabies in the United States: bat-related variants have been identified from 15 of the 28 cases of human rabies diagnosed in the United States since 1980, while contact of any sort with bats could be documented in only seven of the 15 cases (of which 10 were associated with virus from the silver-haired bat variant). These findings indicate that limited physical contact with rabid bats may be associated with rabies virus transmission. In addition, bat bites are small and less likely to be recognized than bites inflicted by many terrestrial animals.
Because bat rabies is enzootic in the contiguous United States (1 ) and reduction of bat populations is not appropriate as a strategy for controlling rabies in bats, human and domestic animal contact with bats should be minimized by the physical exclusion of bats from human dwellings (2 ). Bats should not be captured, handled, or kept as pets. In addition, rabies vaccination should be current for all dogs and cats.
The difference in the number of persons receiving rabies PEP as a result of exposure to the two human rabies cases described in this report (76 versus 12) illustrates variations in the interpretation and systematic application of the Advisory Committee on Immunization Practices (ACIP) guidelines concerning PEP administration (3 ). The number of persons requiring PEP can be minimized by 1) early consideration of rabies as a differential diagnosis in any progressive neurologic disease of unknown etiology, 2) prompt initiation of standard barrier techniques against infectious diseases in the hospital, and 3) strict adherence to ACIP guidelines. --1  1  5  2  -1  22  25  8  6  Hawaii  1  -3  6  2  2  --42  56  --Guam  ----1  2  2  1  -4  --P.R.  ----3  12  57  110  20  53  10  25  V.I. - 
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